Dans le cas des brevets multiples, les fabricants de médicaments génériques craignent que ces brevets ne soient pas authentiques. À leur avis, si on n'a apporté au médicament que des variations mineures, il ne s'agit pas d'authentiques inventions aux termes de la Loi sur les brevets.
The concern of the generics is that then you would have multiple patents, and they've expressed a concern that these multiple patents would not be genuine, or if they're only slight variations, that they would not be genuine inventions as the Patent Act stipulates they must be.